 | • レポートコード：MRC23Q36282 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥406,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥812,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のポイントオブケア（POC）がんスクリーニング市場について調査・分析し、世界のポイントオブケア（POC）がんスクリーニング市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（遺伝子検査、画像検査、その他）、用途別セグメント分析（病院、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Hologic Corporation、Abbott Laboratories、Qiagen N.V.、F Hoffmann-La Roche、BD、Quest Diagnostics、OncoHealth Corp、Danaher、NOVIGENIX SA、Quidel Corporationなどが含まれています。世界のポイントオブケア（POC）がんスクリーニング市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ポイントオブケア（POC）がんスクリーニング市場規模を推定する際に考慮しました。本レポートは、ポイントオブケア（POC）がんスクリーニングの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ポイントオブケア（POC）がんスクリーニングに関するビジネス上の意思決定に役立てることを目的としています。 ・ポイントオブケア（POC）がんスクリーニング市場の概要 - ポイントオブケア（POC）がんスクリーニングのタイプ別セグメント - 世界のポイントオブケア（POC）がんスクリーニング市場規模：タイプ別分析（遺伝子検査、画像検査、その他） - ポイントオブケア（POC）がんスクリーニングの用途別セグメント - 世界のポイントオブケア（POC）がんスクリーニング市場規模：用途別分析（病院、クリニック、その他） - 世界のポイントオブケア（POC）がんスクリーニング市場規模予測（2018年-2029年） ・ポイントオブケア（POC）がんスクリーニング市場の成長トレンド - ポイントオブケア（POC）がんスクリーニングの地域別市場規模（2018年-2029年） - ポイントオブケア（POC）がんスクリーニング市場ダイナミクス - ポイントオブケア（POC）がんスクリーニングの業界動向 - ポイントオブケア（POC）がんスクリーニング市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：遺伝子検査、画像検査、その他 - 世界のポイントオブケア（POC）がんスクリーニングのタイプ別市場規模（2018年-2023年） - 世界のポイントオブケア（POC）がんスクリーニングのタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、クリニック、その他 - 世界のポイントオブケア（POC）がんスクリーニングの用途別市場規模（2018年-2023年） - 世界のポイントオブケア（POC）がんスクリーニングの用途別市場規模（2024年-2029年） ・ポイントオブケア（POC）がんスクリーニングの地域別市場規模 - 北米のポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年） - アメリカのポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年） - ヨーロッパのポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年） - アジア太平洋のポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年） - 中国のポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年） - 日本のポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年） - 韓国のポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年） - インドのポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年） - オーストラリアのポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年） - 中南米のポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年） - 中東・アフリカのポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Hologic Corporation、Abbott Laboratories、Qiagen N.V.、F Hoffmann-La Roche、BD、Quest Diagnostics、OncoHealth Corp、Danaher、NOVIGENIX SA、Quidel Corporation ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Point-of-care Cancer Screening market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Point-of-care Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Point-of-care Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Point-of-care Cancer Screening in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Point-of-care Cancer Screening include Hologic Corporation, Abbott Laboratories, Qiagen N.V., F Hoffmann-La Roche, BD, Quest Diagnostics, OncoHealth Corp, Danaher and NOVIGENIX SA, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Point-of-care Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-care Cancer Screening.
The Point-of-care Cancer Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Point-of-care Cancer Screening market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point-of-care Cancer Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Hologic Corporation
Abbott Laboratories
Qiagen N.V.
F Hoffmann-La Roche
BD
Quest Diagnostics
OncoHealth Corp
Danaher
NOVIGENIX SA
Quidel Corporation
Segment by Type
Genetic Screening
Image Screening
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point-of-care Cancer Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-care Cancer Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Genetic Screening
1.2.3 Image Screening
1.2.4 Others
1.3 Market by Application
1.3.1 Global Point-of-care Cancer Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point-of-care Cancer Screening Market Perspective (2018-2029)
2.2 Point-of-care Cancer Screening Growth Trends by Region
2.2.1 Global Point-of-care Cancer Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Point-of-care Cancer Screening Historic Market Size by Region (2018-2023)
2.2.3 Point-of-care Cancer Screening Forecasted Market Size by Region (2024-2029)
2.3 Point-of-care Cancer Screening Market Dynamics
2.3.1 Point-of-care Cancer Screening Industry Trends
2.3.2 Point-of-care Cancer Screening Market Drivers
2.3.3 Point-of-care Cancer Screening Market Challenges
2.3.4 Point-of-care Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-care Cancer Screening Players by Revenue
3.1.1 Global Top Point-of-care Cancer Screening Players by Revenue (2018-2023)
3.1.2 Global Point-of-care Cancer Screening Revenue Market Share by Players (2018-2023)
3.2 Global Point-of-care Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point-of-care Cancer Screening Revenue
3.4 Global Point-of-care Cancer Screening Market Concentration Ratio
3.4.1 Global Point-of-care Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Cancer Screening Revenue in 2022
3.5 Point-of-care Cancer Screening Key Players Head office and Area Served
3.6 Key Players Point-of-care Cancer Screening Product Solution and Service
3.7 Date of Enter into Point-of-care Cancer Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-care Cancer Screening Breakdown Data by Type
4.1 Global Point-of-care Cancer Screening Historic Market Size by Type (2018-2023)
4.2 Global Point-of-care Cancer Screening Forecasted Market Size by Type (2024-2029)
5 Point-of-care Cancer Screening Breakdown Data by Application
5.1 Global Point-of-care Cancer Screening Historic Market Size by Application (2018-2023)
5.2 Global Point-of-care Cancer Screening Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Point-of-care Cancer Screening Market Size (2018-2029)
6.2 North America Point-of-care Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Point-of-care Cancer Screening Market Size by Country (2018-2023)
6.4 North America Point-of-care Cancer Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point-of-care Cancer Screening Market Size (2018-2029)
7.2 Europe Point-of-care Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Point-of-care Cancer Screening Market Size by Country (2018-2023)
7.4 Europe Point-of-care Cancer Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-care Cancer Screening Market Size (2018-2029)
8.2 Asia-Pacific Point-of-care Cancer Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point-of-care Cancer Screening Market Size (2018-2029)
9.2 Latin America Point-of-care Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Point-of-care Cancer Screening Market Size by Country (2018-2023)
9.4 Latin America Point-of-care Cancer Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-care Cancer Screening Market Size (2018-2029)
10.2 Middle East & Africa Point-of-care Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hologic Corporation
11.1.1 Hologic Corporation Company Detail
11.1.2 Hologic Corporation Business Overview
11.1.3 Hologic Corporation Point-of-care Cancer Screening Introduction
11.1.4 Hologic Corporation Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.1.5 Hologic Corporation Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Point-of-care Cancer Screening Introduction
11.2.4 Abbott Laboratories Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.2.5 Abbott Laboratories Recent Development
11.3 Qiagen N.V.
11.3.1 Qiagen N.V. Company Detail
11.3.2 Qiagen N.V. Business Overview
11.3.3 Qiagen N.V. Point-of-care Cancer Screening Introduction
11.3.4 Qiagen N.V. Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.3.5 Qiagen N.V. Recent Development
11.4 F Hoffmann-La Roche
11.4.1 F Hoffmann-La Roche Company Detail
11.4.2 F Hoffmann-La Roche Business Overview
11.4.3 F Hoffmann-La Roche Point-of-care Cancer Screening Introduction
11.4.4 F Hoffmann-La Roche Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.4.5 F Hoffmann-La Roche Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD Point-of-care Cancer Screening Introduction
11.5.4 BD Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.5.5 BD Recent Development
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Detail
11.6.2 Quest Diagnostics Business Overview
11.6.3 Quest Diagnostics Point-of-care Cancer Screening Introduction
11.6.4 Quest Diagnostics Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.6.5 Quest Diagnostics Recent Development
11.7 OncoHealth Corp
11.7.1 OncoHealth Corp Company Detail
11.7.2 OncoHealth Corp Business Overview
11.7.3 OncoHealth Corp Point-of-care Cancer Screening Introduction
11.7.4 OncoHealth Corp Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.7.5 OncoHealth Corp Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher Point-of-care Cancer Screening Introduction
11.8.4 Danaher Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.8.5 Danaher Recent Development
11.9 NOVIGENIX SA
11.9.1 NOVIGENIX SA Company Detail
11.9.2 NOVIGENIX SA Business Overview
11.9.3 NOVIGENIX SA Point-of-care Cancer Screening Introduction
11.9.4 NOVIGENIX SA Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.9.5 NOVIGENIX SA Recent Development
11.10 Quidel Corporation
11.10.1 Quidel Corporation Company Detail
11.10.2 Quidel Corporation Business Overview
11.10.3 Quidel Corporation Point-of-care Cancer Screening Introduction
11.10.4 Quidel Corporation Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.10.5 Quidel Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details